Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postgrafting Methotrexate and Cyclosporine for GVHD Prevention
NCT00002456Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 1986
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3 trial of methotrexate and cyclosporine in graft-versus-host disease (GVHD), sponsored by Fred Hutchinson Cancer Center. Primary endpoint: Incidence of acute graft versus host disease. Started May 1986; status: completed.
02
Drugs
methotrexatecyclosporine
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00002456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002456.